Stryker to market LifeCell's tissue-based bone graft:
This article was originally published in Clinica
Executive Summary
Stryker Howmedica Osteonics is to be the exclusive marketer of the bone-grafting product currently being developed by LifeCell (Branchburg, New Jersey). The product combines its tissue processing technology and demineralised bone matrix. LifeCell expects the product to be launched by the end of 2003. Under the 10-year deal, Stryker will be responsible for marketing and LifeCell for development, tissue processing and distribution